Cellebrain
Jeonju
About Cellebrain
Cellebrain is a biotechnology company specializing in the development of stem cell-based gene therapy aimed at addressing neurological disorders. The company focuses on advancing therapeutic drugs by utilizing a pipeline of stem cell-based gene therapy candidates. These candidates employ mesenchymal stem cells as cell mediators to deliver therapeutic genes, providing therapy options for patients dealing with chronic stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.2K
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: cellebrain.com
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/cellebrain-2297659 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.